Interfant 99: International collaborative treatment protocol for infants under one year with acute lymphoblastic leukaemia

Completed

• Conditions: Acute lymphoblastic leukaemia (ALL); Cancer; Lymphoid leukaemia

• Registration Number: ISRCTN24251487
• Lead Sponsor: Interfant Collaborative Group (Netherlands)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2005-12-20
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 500

Inclusion Criteria

1. Aged less than 366 days
2. Acute lymphoblastic leukaemia

Exclusion Criteria

Prior therapy for leukaemia (except emergency treatment).

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Event free survival

Secondary Outcome Measures

Name	Time	Method
Added as of 24/07/2007: Survival